Purfem
Natural health product licensed in Canada
- Licence holder
- Aralez Pharmaceuticals Canada Inc.
- NPN or DIN-HM
- 80039387
- Status
- Inactive licence
- Licence date
- 31 January 2013
- Revision date
- 19 February 2013
- Form
- Pessaire
- Route of administration
- Vaginale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lactobacillus gasseri Source : DSM 14869 | 430 Millions d'UFC |
Non-medicinal ingredients
Maize starch, Stéarate de magnésium, Gomme de xanthane, Lactitol, Gélatine, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Ovule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To help prevent recurrent bacterial vaginosis after initial treatment with antibiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039387
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed. Photograph the packaging